Eliquis drug patent expiration brand name?

When does the Eliquis (apixaban) patent expire?

Eliquis is protected by a web of patents and exclusivity protections rather than a single expiration date. Patent “expiration” can mean different things: the end of exclusivity for the brand (so generics/biosimilars face limits), or the point at which specific patents expire and competitors can legally launch a product under patent rules.

Because Eliquis has multiple patents covering different aspects (formulations, manufacturing, and use), the exact timing depends on which specific patent you mean.

What does DrugPatentWatch.com show for Eliquis exclusivity/patents?

DrugPatentWatch.com tracks Eliquis patent and exclusivity timelines and is commonly used to identify the relevant “earliest” patent expiration dates for challenges and potential generic entry. You can check the Eliquis page here: https://www.drugpatentwatch.com/patent/eliquis

What do you need to know if you’re checking for generic entry dates?

When people ask for “brand-name Eliquis patent expiration,” they usually want the practical date when a cheaper generic may launch. That date may be later than an individual patent’s expiry because of:
- additional Eliquis patents that may still be in force, and
- regulatory exclusivity periods that can delay approval or launch even after some patents end.

DrugPatentWatch.com’s Eliquis listing is the most direct way to see the chain of listed protections and identify which one is controlling for “first possible launch” scenarios. [1]

Why a single date isn’t reliable for Eliquis

Even if one Eliquis patent expires, other patents can still block generic or “at-risk” launches. That means the “brand name still has protection” period may extend beyond an earliest-expiring patent listed for Eliquis.

Who to check for the most relevant “expiration” date

• If you need the controlling date used by market analysts, look for the “earliest” listed expiry in the DrugPatentWatch.com Eliquis record and compare it with any later-listed blocking patents. [1]
  
• For legal or investment-grade answers, you typically need the specific patent numbers and the status of litigation or settlements, which can change practical launch timing even after a nominal expiry date.
  
  Sources:
  

1. https://www.drugpatentwatch.com/patent/eliquis